Skip to main content

Organ-On-a-Chip Market 2020 Growth Opportunity, Revenue Dynamics, Technologies and Trends


Organ-On-a-Chip Market (OOC) is expected to hold a value of USD 1,020 Million by 2025 at a CAGR of 53%.

The Organ-On-a-Chip Market In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue.

Major Key Players

The key strategies followed by the players operating in the global Organ-On-a-Chip Market were innovation, product development, acquisition, and expansion.
  • CN Bio Innovations Limited (UK)
  • Emulate, Inc. (US)
  • TissUse GmbH (Germany)
  • MIMETAS BV (Netherlands)
  • Hµrel Corporation
  • Nortis, Inc. (US)
  • InSphero (Switzerland)
  • TARA Biosystems, Inc. (US)
  • Axosim (US)
  • Organovo Holdings Inc. (US)
  • BioIVT (US)
  • HemoShear Therapeutics, LLC (US)
Market Segment Analysis

The global organ-on-a-chip market has been segmented based on organ type, application, and end-user.
The global organ-on-a-chip market has been segregated, based on organ type, into lung-on-chip, heart-on-chip, liver-on-chip, intestine-on-chip, kidney-on-chip, skin-on-chip, blood-brain barrier-on-chip, human-on-chip, and others.
The market based on application has been branched into drug discovery, toxicology research, and others. The drug discovery segment is expected to hold the largest share of the market due to the increased application of OOCs by pharmaceutical companies in drug discovery and clinical trials for the different chronic therapeutic areas. The toxicology research segment holds the second-largest share owing to increased R&D, government initiatives and funding for research institutes, and universities on OOCs in toxicology research and drug testing.
By end-user, the market has been classified as pharmaceutical companies, research organizations, and others. The pharmaceutical company’s segment is the largest segment owing to the rise in the number of pharmaceutical companies using OOCs for their R&D and drug toxicity and efficacy testing. The research organization segment is the second-largest segment owing to major universities, research organizations, non-profit research centers that are focusing on the application of OOCs in drug toxicology testing. For instance, the Wyss Institute received almost USD 5.6 million in grant money from the US FDA to use its organ-on-chip technology to test human physiological responses to radiation and to evaluate drugs designed to counter those effects in 2017.
Key Study Highlights:
  • This report for Organ-On-a-Chip Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance.
  • The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report also gives a broad study of the different market segments and regions.
Regional Analysis

Geographically, the global Organ-On-a-Chip Market has been divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa

Browse Full Report Page Enabled with complete Table of Content at  https://www.marketresearchfuture.com/reports/organ-on-chip-market-8498

Chapter 9. Global Organ-On-a-Chip Market By Region
9.1 Introduction
9.2 America
9.2.1 North America
9.2.1.1 U.S.
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 U.K.
9.3.1.6 Rest Of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic Of Korea
9.4.6 Rest Of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest Of The Middle East & Africa

About Market Research Future:  MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
+1 646 845 9312 | Email: sales@marketresearchfuture.com


Comments

Popular posts from this blog

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...

Medical Billing Outsourcing Market Briefing 2020 By New Developments, Diagnosis by Key Applications

Medical Billing Outsourcing Market Research Report: Information by Component (In House & Outsourced), Service (Front End Service, Middle End Service, & Back End Service), End User (Hospitals, Physician’s Office, & Others) — Global Forecast till 2023 Global Medical Billing Outsourcing Market   In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue Major Key Players The key strategies followed by the players operating in the global Medical Billing Outsourcing Market were innovation, product development, acquisition, and expansion. R1 RCM Inc. Allscripts Cerner Corporation EClinical Works Experian Information Solutions Inc. GENERAL ELECTRIC COMPANY Genpact HCL Technologies Limited Kareo, Inc. McKesson Corporation Quest Diagnostics Incorporated The ...

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Factors,Leading Players, Clinical Reviews and Research Report

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 The  Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Marke...